BCA Assay Kit: Mechanism, Protocol, and Troubleshooting Guide

By Dr. Zubair Khalid, DVM, MS, PhD ·

BCA Assay Kit: Mechanism, Protocol, and Troubleshooting Guide

Introduction to the BCA Assay Kit

What is the BCA Assay?

The bicinchoninic acid (BCA) assay is a colorimetric method for quantitative determination of total protein concentration in aqueous solutions. Developed by Paul K. Smith and colleagues in 1985, the BCA assay kit combines the biuret reaction—the reduction of cupric ions (Cu²⁺) to cuprous ions (Cu⁺) by peptide bonds under alkaline conditions—with the highly sensitive and selective chromogenic detection of Cu⁺ using bicinchoninic acid. The resulting purple-colored complex exhibits strong absorbance at 562 nm, with a linear relationship between absorbance and protein concentration across a working range of approximately 20–2,000 µg/mL, depending on the specific kit formulation.

The BCA assay kit is distinguished from other protein quantification methods by its compatibility with a broad range of detergents (up to 5% SDS, for example), its tolerance for reducing agents at moderate concentrations, and its endpoint stability. Unlike the Bradford assay, which relies on dye binding to basic and aromatic amino acid residues, the BCA assay measures peptide bonds themselves, making it less susceptible to amino acid composition bias. This mechanistic difference means that BCA results more closely reflect true protein mass rather than the abundance of specific residues.

Applications in Protein Biochemistry

The BCA assay kit serves as a foundational analytical tool across nearly every branch of protein biochemistry. Typical applications include:

  • Quantifying protein yields after cell lysis, ammonium sulfate precipitation, or chromatographic purification steps, such as those used in His Tag Protein Purification workflows.
  • Normalizing samples prior to downstream analyses, including SDS-PAGE loading, enzymatic activity assays, or immunoprecipitation experiments such as the Co-immunoprecipitation Assay.
  • Measuring protein content in complex biological matrices, including serum, plasma, tissue homogenates, and cell culture lysates.
  • Validating protein concentration consistency across batches during Assay Method Validation protocols.
  • Supporting structural biology pipelines, where accurate protein concentration is critical before setting up crystallization screens for X Ray Crystallography.

The assay's robustness, simplicity, and compatibility with high-throughput microplate formats have made it a standard method in virtually all molecular biology laboratories.

Chemical Mechanism of the BCA Assay

Step 1: Biuret Reaction

The BCA assay proceeds through two coupled chemical reactions. The first is the biuret reaction, in which peptide bonds in proteins chelate cupric ions (Cu²⁺) under alkaline conditions. The term "biuret reaction" derives from the organic compound biuret (H₂N-CO-NH-CO-NH₂), which forms a violet complex with copper salts in alkaline solution—a reaction first described in the 19th century.

In the context of the BCA assay, the alkaline environment (typically pH 11–12, maintained by sodium hydroxide and sodium carbonate in Reagent A) deprotonates the amide nitrogen atoms of peptide bonds. The resulting negatively charged nitrogen atoms coordinate with Cu²⁺, forming a tetradentate complex. This complex is unstable and undergoes a redox reaction in which Cu²⁺ is reduced to Cu⁺. The stoichiometry is approximately one Cu⁺ produced per two peptide bonds, though this ratio varies with protein structure and amino acid composition. Cysteine, cystine, tryptophan, and tyrosine residues also contribute to copper reduction, which is why the BCA assay exhibits slight protein-to-protein variability.

The biuret reaction alone produces a weak blue color with absorbance maximum around 540 nm, but this signal is insufficient for sensitive protein quantification. The reaction's real value lies in generating Cu⁺, which serves as the substrate for the second, highly sensitive detection step.

Step 2: BCA-Cu⁺ Complex Formation

The second reaction involves bicinchoninic acid, a chromogenic reagent that specifically chelates cuprous ions. BCA (C₂₀H₁₀N₂Na₂O₄) contains two carboxylate groups and two nitrogen atoms that coordinate with Cu⁺ in a 2:1 stoichiometry, forming a stable, intensely purple-colored complex.

The formation of the BCA-Cu⁺ complex is highly specific for the reduced form of copper. BCA does not form a colored complex with Cu²⁺, which ensures that the assay signal is directly proportional to the amount of Cu⁺ generated in the biuret reaction, and therefore proportional to the amount of protein present. The stability constant of the BCA-Cu⁺ complex is exceptionally high, which drives the equilibrium of the biuret reaction forward and amplifies the signal.

Each Cu⁺ ion binds two BCA molecules, and the resulting complex has a molar extinction coefficient of approximately 7,700 L·mol⁻¹·cm⁻¹ at 562 nm. This high extinction coefficient, combined with the amplification inherent in the two-step mechanism, gives the BCA assay its sensitivity—approximately 100-fold more sensitive than the traditional Lowry assay and comparable to the Bradford assay.

Absorbance and Color Development

The BCA-Cu⁺ complex absorbs maximally at 562 nm, which falls in the visible spectrum and can be measured with any standard spectrophotometer or microplate reader equipped with a 562 nm filter. The absorbance at 562 nm increases linearly with protein concentration over the assay's working range, enabling quantitative determination through comparison with a standard curve.

Color development is time- and temperature-dependent. At room temperature (20–25°C), the reaction reaches completion in approximately 2 hours. At 37°C, the reaction completes in 30 minutes, and at 60°C, in 15 minutes. The enhanced temperature accelerates the biuret reaction and subsequent BCA-Cu⁺ complex formation. However, elevated temperatures also increase the contribution of cysteine, cystine, and tryptophan residues to copper reduction, which can slightly alter the assay's protein-to-protein consistency.

The BCA-Cu⁺ complex is stable for several hours after reaching completion, with absorbance increasing only minimally (approximately 1–2% per hour) at room temperature. This endpoint stability is a practical advantage over the Bradford assay, whose dye-protein complex can precipitate over time, and over the Lowry assay, whose color continues to develop slowly.

Reagents and Kit Components

Reagent A and Reagent B

A typical BCA assay kit consists of two reagents, designated Reagent A and Reagent B, which are mixed immediately before use to form the working reagent.

Reagent A is an alkaline carbonate-bicarbonate buffer containing:

  • Sodium carbonate monohydrate (Na₂CO₃·H₂O), typically 2% (w/v)
  • Sodium bicarbonate (NaHCO₃), typically 0.95% (w/v)
  • Sodium tartrate dihydrate (Na₂C₄H₄O₆·2H₂O), typically 0.16% (w/v)
  • Bicinchoninic acid, typically 1% (w/v)
  • Sodium hydroxide (NaOH) to adjust pH to approximately 11.25

The sodium tartrate serves as a stabilizer, preventing precipitation of copper salts and maintaining the solubility of the reaction components. The carbonate-bicarbonate pair provides the alkaline buffering capacity essential for the biuret reaction.

Reagent B is a 4% (w/v) cupric sulfate pentahydrate (CuSO₄·5H₂O) solution. This reagent supplies the Cu²⁺ that is reduced to Cu⁺ during the biuret reaction. The copper concentration in the final working reagent is approximately 0.4% (w/v), which provides sufficient Cu²⁺ to support the assay's dynamic range without causing precipitation.

Working Reagent Preparation

The working reagent is prepared by mixing Reagent A and Reagent B in a 50:1 ratio (50 parts Reagent A to 1 part Reagent B). For example, to prepare 10 mL of working reagent, combine 9.8 mL of Reagent A with 0.2 mL of Reagent B.

The working reagent has a characteristic apple-green color due to the presence of Cu²⁺ in the alkaline carbonate solution. It is stable for approximately 24 hours when stored at room temperature in a closed container, though preparation immediately before use is recommended for optimal consistency. The working reagent should be clear; any turbidity or precipitate indicates contamination or reagent degradation, and the reagent should be discarded.

Standard Protein Solutions

BCA assay kits include a protein standard, most commonly bovine serum albumin (BSA) at a concentration of 2 mg/mL in 0.9% saline with 0.05% sodium azide as a preservative. Some kits offer bovine gamma-globulin (BGG) as an alternative standard, which may be more appropriate when quantifying immunoglobulin-containing samples.

The choice of standard is important because different proteins produce slightly different color responses in the BCA assay due to variations in amino acid composition. BSA is the most commonly used standard and is appropriate for most applications. For samples whose protein composition differs substantially from BSA (e.g., highly glycosylated proteins or membrane proteins), results should be interpreted as "BSA equivalents" rather than absolute protein concentrations.

Step-by-Step BCA Assay Protocol

Sample Preparation and Dilution

Proper sample preparation is critical for accurate BCA quantification. Samples should be clarified by centrifugation (10,000 × g for 10 minutes at 4°C) to remove particulates that would scatter light and inflate absorbance readings. For cell lysates prepared in buffers containing detergents, the sample should be clear after centrifugation; turbidity suggests incomplete lysis or precipitation.

The protein concentration of the sample should be estimated to determine the appropriate dilution. Most BCA kits have a working range of 20–2,000 µg/mL. Samples exceeding this range must be diluted in the same buffer used for the standards. Ideally, the dilution buffer should match the sample buffer to minimize matrix effects. If the sample buffer contains interfering substances (discussed in Section 6), dilution may reduce their concentration below the interference threshold.

For unknown samples, it is prudent to test two or three dilutions (e.g., 1:5, 1:10, and 1:20) to ensure that at least one falls within the linear range of the standard curve. This practice also helps identify interference, as serial dilutions of a clean sample should yield consistent calculated concentrations.

Preparation of Standards

Prepare a dilution series of the protein standard (typically BSA at 2 mg/mL) in the same buffer as the samples. A standard protocol for a 2,000 µg/mL top standard uses the following dilution scheme in microcentrifuge tubes:

  1. Label eight tubes: A through H.
  2. Add 300 µL of the 2 mg/mL BSA stock to tube A (2,000 µg/mL).
  3. Add 375 µL of dilution buffer to tubes B through H.
  4. Transfer 375 µL from tube A to tube B and mix thoroughly (1,000 µg/mL).
  5. Transfer 375 µL from tube B to tube C and mix (500 µg/mL).
  6. Continue this serial 1:1 dilution through tube G (15.6 µg/mL).
  7. Tube H contains only dilution buffer (0 µg/mL, the blank).

This scheme produces standards at 2,000, 1,000, 500, 250, 125, 62.5, 31.25, and 15.6 µg/mL. The blank (0 µg/mL) is essential for zeroing the spectrophotometer and correcting for any background absorbance from the buffer.

Assay Procedure

The following protocol is for a microplate format, which is the most common and high-throughput approach:

  1. Pipette 25 µL of each standard and sample into the appropriate wells of a 96-well microplate. Run standards and samples in duplicate or triplicate.
  2. Prepare the working reagent by mixing 50 parts Reagent A with 1 part Reagent B. Prepare sufficient volume for all wells, plus excess for pipetting error. For a full 96-well plate with 200 µL per well, prepare at least 20 mL of working reagent.
  3. Add 200 µL of working reagent to each well using a multichannel pipettor. Mix thoroughly on a plate shaker for 30 seconds. The final sample-to-working-reagent ratio is 1:8 (25 µL sample + 200 µL reagent).
  4. Cover the plate to prevent evaporation and incubate at 37°C for 30 minutes.
  5. Cool the plate to room temperature.
  6. Measure the absorbance at 562 nm on a microplate reader. If a 562 nm filter is unavailable, 540–590 nm filters can be used with reduced sensitivity.

Incubation and Measurement

The standard incubation for the BCA assay is 30 minutes at 37°C. This condition provides a good balance between sensitivity and speed, with the reaction reaching approximately 90% completion. Alternative conditions include:

  • Room temperature (25°C) for 2 hours: Produces a slightly lower signal but minimizes the contribution of cysteine and tryptophan residues to copper reduction, improving protein-to-protein consistency.
  • 60°C for 15 minutes: Produces the highest signal but increases variability and the risk of precipitation with samples containing high lipid or carbohydrate content.
  • Enhanced protocol (60°C for 30 minutes): Extends the working range to 5–250 µg/mL for microplate applications, useful for dilute samples.

After incubation, the plate should be cooled to room temperature before measurement, as absorbance readings are temperature-dependent. The color is stable for at least 1 hour at room temperature, allowing flexibility in measurement timing.

Standard Curve and Data Analysis

Constructing the Standard Curve

After measuring the absorbance of the standards, construct a standard curve by plotting absorbance at 562 nm (y-axis) against protein concentration (x-axis). The relationship is linear over the working range, and the data should be fitted with a linear regression equation:

A₅₆₂ = m × [protein] + b

where m is the slope and b is the y-intercept. The blank (0 µg/mL) should have an absorbance close to zero, typically less than 0.1. A well-constructed standard curve should have an R² value of at least 0.98.

For microplate readers, the path length is determined by the volume and well geometry, not the cuvette path length. Most plate readers report absorbance in "well units" that are proportional to, but not identical to, cuvette-based absorbance. This does not affect concentration calculations as long as standards and samples are measured under identical conditions.

Calculating Sample Concentrations

Once the standard curve equation is established, calculate the protein concentration of each sample by solving for x:

[protein] = (A₅₆₂ − b) / m

Multiply by the dilution factor to obtain the concentration of the original sample. For example, if a sample was diluted 1:10 before assay and the calculated concentration from the standard curve is 150 µg/mL, the original concentration is 1,500 µg/mL (1.5 mg/mL).

It is essential to verify that the sample absorbance falls within the range of the standard curve. Values below the lowest standard are unreliable due to poor signal-to-noise ratio. Values above the highest standard exceed the linear range and must be re-assayed at a higher dilution.

Statistical Considerations

For reliable results, run standards and samples in duplicate or triplicate. Calculate the mean absorbance for each standard and sample, and use the mean values for standard curve construction and concentration determination.

The coefficient of variation (CV) between replicates should be less than 10% for samples and less than 5% for standards. High CVs indicate pipetting errors, incomplete mixing, or the presence of interfering substances. Outliers can be identified using Grubbs' test or by examining residuals from the regression line. Remove outliers only if there is a documented technical reason (e.g., air bubbles in the well, visible precipitate).

When comparing protein concentrations across different samples or experimental conditions, use appropriate statistical tests (t-test for two groups, ANOVA for multiple groups) on the calculated concentrations, not on the raw absorbance values, unless the standard curve passes through the origin.

Compatibility and Interfering Substances

The BCA assay is compatible with many common laboratory reagents, but certain substances interfere with the reaction. Understanding these interferences is essential for obtaining accurate results.

Reducing Agents

Reducing agents are among the most problematic interferents in the BCA assay. Compounds such as dithiothreitol (DTT), β-mercaptoethanol (BME), and tris(2-carboxyethyl)phosphine (TCEP) reduce Cu²⁺ to Cu⁺ directly, independent of protein, producing a false-positive signal that inflates absorbance readings.

The severity of interference depends on the reducing agent and its concentration:

Reducing AgentMaximum Tolerable Concentration
DTT1 mM
β-Mercaptoethanol10 mM
TCEP1 mM
Sodium azide0.1% (w/v)

At concentrations above these thresholds, the assay produces artificially high readings that cannot be corrected by subtracting a blank, because the interference is concentration-dependent and nonlinear.

Detergents and Lipids

The BCA assay is notably more detergent-compatible than the Bradford assay. Most nonionic and anionic detergents are tolerated at concentrations up to 5% (w/v), including Triton X-100, Tween-20, Tween-80, and sodium dodecyl sulfate (SDS). This compatibility makes the BCA assay the method of choice for quantifying proteins in cell lysates prepared with detergents.

However, certain detergents cause precipitation or turbidity:

  • Cetyltrimethylammonium bromide (CTAB) and other cationic detergents precipitate with the BCA reagent.
  • Sodium dodecyl sulfate (SDS) at concentrations above 5% can cause precipitation.
  • Lipids at high concentrations (>1%) can cause turbidity and interfere with absorbance measurements.

Chelating Agents

Chelating agents such as ethylenediaminetetraacetic acid (EDTA) and ethylene glycol-bis(β-aminoethyl ether)-N,N,N′,N′-tetraacetic acid (EGTA) interfere with the BCA assay by sequestering Cu²⁺, preventing its participation in the biuret reaction. This results in a false-negative signal (underestimation of protein concentration).

The maximum tolerable concentration of EDTA is approximately 10 mM, though this depends on the copper concentration in the working reagent. At higher EDTA concentrations, the assay becomes unreliable regardless of protein concentration.

Mitigation Strategies

Several strategies can mitigate interference from incompatible substances:

  1. Dilution: If the interfering substance is present at a concentration only slightly above the tolerance threshold, dilution of the sample may bring it below the threshold. This requires that the protein concentration remains within the assay's working range after dilution.
  1. Protein precipitation: For samples containing high concentrations of interfering substances, precipitate proteins using trichloroacetic acid (TCA) or acetone, then redissolve the pellet in a compatible buffer. This removes most small-molecule interferents but requires additional sample handling and may result in protein loss.
  1. Buffer exchange: Dialyze or desalt the sample using a size-exclusion spin column to remove low-molecular-weight interferents while retaining proteins.
  1. Alternative assay: If interference cannot be eliminated, consider using the Bradford assay, which is compatible with reducing agents and chelators, though it is incompatible with detergents. See Section 8 for a detailed comparison.

Troubleshooting and Common Pitfalls

High Background Absorbance

Symptom: The blank (0 µg/mL standard) shows absorbance greater than 0.1 at 562 nm.

Causes and solutions:

  • Contaminated buffer: The dilution buffer may contain reducing agents or other copper-reactive substances. Prepare fresh buffer and verify its purity.
  • Aged working reagent: The working reagent may have oxidized or absorbed CO₂ from the air, increasing background. Prepare fresh working reagent.
  • Cross-contamination: Pipette tips may carry over sample or standard between wells. Use fresh tips for each addition.
  • Incorrect wavelength: Verify that the plate reader is set to 562 nm. Readings at lower wavelengths will show higher background.

Non-Linear Standard Curve

Symptom: The standard curve deviates from linearity, particularly at high or low concentrations.

Causes and solutions:

  • Saturation at high concentrations: Absorbance values above 1.5–2.0 exceed the linear range of most plate readers. Dilute the standards or use a shorter path length.
  • Incomplete mixing: The working reagent and standard may not be thoroughly mixed, causing well-to-well variability. Mix the plate on a shaker for 30 seconds after adding the working reagent.
  • Evaporation during incubation: Wells at the plate edges may lose volume during incubation, concentrating the sample. Cover the plate and consider using a humidified incubator.
  • Pipetting errors: Serial dilutions amplify pipetting errors. Use calibrated pipettes and mix thoroughly at each dilution step.

Sample Precipitation

Symptom: Visible precipitate or turbidity in wells after adding the working reagent.

Causes and solutions:

  • High lipid content: Lipids can precipitate in the alkaline BCA reagent. Centrifuge the sample after incubation and measure the supernatant, or use a lipid removal reagent.
  • High carbohydrate content: Carbohydrates at concentrations above 10 mM can cause precipitation. Dilute the sample or use a different assay.
  • Detergent incompatibility: Some detergents, particularly cationic ones, precipitate with the BCA reagent. Switch to a compatible detergent or use the Bradford assay.
  • High protein concentration: Protein concentrations above 5 mg/mL can cause precipitation. Dilute the sample.

Incorrect Incubation Time

Symptom: Absorbance values are lower or higher than expected, or the standard curve is non-linear.

Causes and solutions:

  • Insufficient incubation: At 37°C, the reaction requires at least 30 minutes to approach completion. Shorter incubation times produce lower signals and a compressed standard curve.
  • Excessive incubation: Incubation beyond 60 minutes at 37°C increases the contribution of cysteine and tryptophan residues to copper reduction, causing the standard curve to become non-linear at high concentrations.
  • Temperature variation: The incubator may not be at the set temperature. Verify with a calibrated thermometer. Uneven heating across the plate can cause edge effects.

Comparison with Other Protein Assays

The choice of protein quantification method depends on sample composition, sensitivity requirements, and compatibility with interfering substances. The following table summarizes key differences:

ParameterBCA AssayBradford AssayLowry AssayUV A₂₈₀
MechanismCu²⁺ reduction + BCA chelationCoomassie dye bindingCu²⁺ reduction + Folin reagentIntrinsic absorbance
Sensitivity range20–2,000 µg/mL1–1,500 µg/mL5–1,500 µg/mL50–3,000 µg/mL
Detergent compatibilityExcellent (up to 5%)Poor (precipitates)ModerateExcellent
Reducing agent compatibilityPoorExcellentPoorExcellent
Chelator compatibilityPoorExcellentPoorExcellent
Protein-to-protein variabilityLowHighModerateLow
Time to result30–60 min5–15 min40–60 min<1 min
Endpoint stabilityHoursMinutesHoursN/A

BCA vs. Bradford

The Bradford assay, which uses Coomassie Brilliant Blue G-250 dye, is faster (5 minutes) and more sensitive at low protein concentrations (detection limit approximately 1 µg/mL). However, it exhibits significant protein-to-protein variability because the dye binds primarily to arginine, lysine, and histidine residues. Basic proteins produce a stronger signal per unit mass than acidic proteins, leading to overestimation or underestimation depending on the standard used.

The Bradford assay is compatible with reducing agents and chelators but is incompatible with detergents, which precipitate the dye-protein complex. The BCA assay is the better choice for samples containing detergents, such as cell lysates, and for applications requiring minimal protein-to-protein variability.

BCA vs. Lowry

The Lowry assay, developed in 1951, also relies on the biuret reaction followed by reduction of the Folin-Ciocalteu phenol reagent. It offers sensitivity comparable to the BCA assay but requires a 10-minute incubation at room temperature followed by a 30-minute incubation, with strict timing requirements. The Folin reagent is unstable and must be prepared fresh, and the assay is incompatible with many buffers and detergents.

The BCA assay is essentially an improved Lowry assay with a more stable detection reagent, simpler protocol, and broader compatibility. The BCA assay has largely replaced the Lowry assay in modern laboratories.

BCA vs. UV A₂₈₀

Direct UV absorbance at 280 nm measures the intrinsic absorbance of tryptophan and tyrosine residues. It is the simplest and fastest method, requiring no reagents or incubation. However, it is insensitive (detection limit approximately 50 µg/mL), subject to interference from nucleic acids (which absorb at 260 nm and tail into the 280 nm region), and highly dependent on amino acid composition. A protein lacking tryptophan and tyrosine residues would produce no signal.

UV A₂₈₀ is best used for purified proteins with known extinction coefficients, where it provides accurate, non-destructive quantification. For complex mixtures and crude samples, the BCA assay is more reliable.

Practical Summary and Best Practices

Key Takeaways

  • The BCA assay kit quantifies protein by detecting peptide bonds through a two-step mechanism: Cu²⁺ reduction to Cu⁺ in alkaline conditions, followed by chromogenic chelation of Cu⁺ by bicinchoninic acid.
  • The assay has a working range of approximately 20–2,000 µg/mL and produces a stable purple color with absorbance measured at 562 nm.
  • The BCA assay is compatible with detergents up to 5%, making it ideal for quantifying proteins in cell lysates and other detergent-containing samples.
  • Reducing agents (DTT, BME, TCEP) and chelators (EDTA, EGTA) interfere with the assay and must be removed or diluted below their tolerance thresholds.
  • The standard curve should be linear with R² ≥ 0.98; deviations indicate pipetting errors, incomplete mixing, or interfering substances.
  • The BCA assay offers better protein-to-protein consistency than the Bradford assay and broader reagent compatibility than the Lowry assay.

Quick Checklist for Reliable Results

  • Prepare fresh working reagent (50:1 Reagent A:B) immediately before use.
  • Verify that the working reagent is clear and apple-green in color.
  • Run standards and samples in duplicate or triplicate.
  • Use the same buffer for standards and samples.
  • Include a blank (0 µg/mL standard) to correct for background.
  • Incubate at 37°C for exactly 30 minutes.
  • Cool the plate to room temperature before measuring absorbance.
  • Verify that sample absorbance falls within the standard curve range.
  • Check that the standard curve R² ≥ 0.98.
  • Confirm that replicate CVs are below 10% for samples and 5% for standards.
  • Dilute samples containing reducing agents or chelators below interference thresholds.
  • Centrifuge turbid samples before assay to remove particulates.

Frequently Asked Questions

What is the BCA assay kit protocol?

The standard BCA assay kit protocol involves: (1) preparing a BSA standard dilution series (0–2,000 µg/mL), (2) pipetting 25 µL of standards and samples into a 96-well plate, (3) adding 200 µL of working reagent (50:1 Reagent A:B) to each well, (4) mixing on a plate shaker for 30 seconds, (5) incubating at 37°C for 30 minutes, (6) cooling to room temperature, and (7) measuring absorbance at 562 nm. Calculate protein concentrations from the standard curve after subtracting the blank.

How does the BCA assay work?

The BCA assay works through two coupled reactions. First, peptide bonds in proteins chelate Cu²⁺ under alkaline conditions (the biuret reaction), reducing it to Cu⁺. Second, bicinchoninic acid specifically chelates Cu⁺, forming an intensely purple complex with absorbance at 562 nm. The amount of Cu⁺ produced is proportional to the amount of protein present, so absorbance at 562 nm correlates linearly with protein concentration.

What substances interfere with the BCA assay?

Reducing agents (DTT, β-mercaptoethanol, TCEP) interfere by directly reducing Cu²⁺ to Cu⁺, causing false-positive signals. Chelating agents (EDTA, EGTA) interfere by sequestering Cu²⁺, preventing the biuret reaction and causing false-negative signals. High concentrations of lipids can cause turbidity. Cationic detergents such as CTAB precipitate with the BCA reagent. The maximum tolerable concentrations are approximately 1 mM DTT, 10 mM β-mercaptoethanol, 1 mM TCEP, and 10 mM EDTA.

Can I use the BCA assay with detergents?

Yes, the BCA assay is compatible with most detergents at concentrations up to 5% (w/v), including Triton X-100, Tween-20, Tween-80, and SDS. This is a major advantage over the Bradford assay, which precipitates in the presence of detergents. However, cationic detergents such as CTAB and cetylpyridinium chloride are incompatible and cause precipitation.

What is the detection range of the BCA assay?

The standard BCA assay has a working range of approximately 20–2,000 µg/mL. With the enhanced protocol (60°C incubation for 30 minutes), the range extends to 5–250 µg/mL for microplate applications. The micro BCA assay, which uses a different reagent-to-sample ratio, extends the detection limit to approximately 0.5–20 µg/mL.

Why is my BCA standard curve not linear?

A non-linear standard curve typically results from pipetting errors in the serial dilution, incomplete mixing of the working reagent, evaporation during incubation (especially in edge wells), or absorbance values exceeding the linear range of the plate reader (above approximately 2.0). Verify pipette calibration, mix thoroughly after adding working reagent, cover the plate during incubation, and ensure that the highest standard does not produce absorbance above 2.0.

How do I choose between BCA and Bradford assays?

Choose the BCA assay when samples contain detergents (such as cell lysates), when protein-to-protein consistency is critical, or when you need endpoint stability. Choose the Bradford assay when samples contain reducing agents or chelators, when you need results in under 10 minutes, or when sample volume is limited (Bradford requires only 5–10 µL). For purified proteins with known extinction coefficients, UV A₂₈₀ is the simplest option. For high-throughput screening applications, consider Automated Protein Quantification platforms that integrate these methods.

Related Clinical & Scientific Guides